rs8190364
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The ENST00000692152.1(CYB5R3):c.-48-12741G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00627 in 151,950 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0063 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0028 ( 0 hom. )
Consequence
CYB5R3
ENST00000692152.1 intron
ENST00000692152.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.971
Publications
0 publications found
Genes affected
CYB5R3 (HGNC:2873): (cytochrome b5 reductase 3) This gene encodes cytochrome b5 reductase, which includes a membrane-bound form in somatic cells (anchored in the endoplasmic reticulum, mitochondrial and other membranes) and a soluble form in erythrocytes. The membrane-bound form exists mainly on the cytoplasmic side of the endoplasmic reticulum and functions in desaturation and elongation of fatty acids, in cholesterol biosynthesis, and in drug metabolism. The erythrocyte form is located in a soluble fraction of circulating erythrocytes and is involved in methemoglobin reduction. The membrane-bound form has both membrane-binding and catalytic domains, while the soluble form has only the catalytic domain. Alternate splicing results in multiple transcript variants. Mutations in this gene cause methemoglobinemias. [provided by RefSeq, Jan 2010]
CYB5R3 Gene-Disease associations (from GenCC):
- methemoglobinemiaInheritance: AR Classification: DEFINITIVE Submitted by: Illumina
- methemoglobinemia due to deficiency of methemoglobin reductaseInheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- hereditary methemoglobinemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00628 (952/151588) while in subpopulation NFE AF = 0.0109 (740/67920). AF 95% confidence interval is 0.0102. There are 5 homozygotes in GnomAd4. There are 439 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CYB5R3 | NM_000398.7 | c.-272G>A | upstream_gene_variant | ENST00000352397.10 | NP_000389.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CYB5R3 | ENST00000352397.10 | c.-272G>A | upstream_gene_variant | 1 | NM_000398.7 | ENSP00000338461.6 |
Frequencies
GnomAD3 genomes AF: 0.00628 AC: 952AN: 151472Hom.: 5 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
952
AN:
151472
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00276 AC: 1AN: 362Hom.: 0 Cov.: 0 AF XY: 0.00459 AC XY: 1AN XY: 218 show subpopulations
GnomAD4 exome
AF:
AC:
1
AN:
362
Hom.:
Cov.:
0
AF XY:
AC XY:
1
AN XY:
218
show subpopulations
African (AFR)
AF:
AC:
0
AN:
2
American (AMR)
AF:
AC:
0
AN:
18
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
6
East Asian (EAS)
AF:
AC:
0
AN:
4
South Asian (SAS)
AF:
AC:
0
AN:
4
European-Finnish (FIN)
AF:
AC:
0
AN:
8
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
1
AN:
300
Other (OTH)
AF:
AC:
0
AN:
20
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00628 AC: 952AN: 151588Hom.: 5 Cov.: 32 AF XY: 0.00593 AC XY: 439AN XY: 74026 show subpopulations
GnomAD4 genome
AF:
AC:
952
AN:
151588
Hom.:
Cov.:
32
AF XY:
AC XY:
439
AN XY:
74026
show subpopulations
African (AFR)
AF:
AC:
67
AN:
41412
American (AMR)
AF:
AC:
18
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
18
AN:
3468
East Asian (EAS)
AF:
AC:
1
AN:
4914
South Asian (SAS)
AF:
AC:
4
AN:
4770
European-Finnish (FIN)
AF:
AC:
90
AN:
10520
Middle Eastern (MID)
AF:
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
AC:
740
AN:
67920
Other (OTH)
AF:
AC:
12
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
50
100
151
201
251
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.